Document ID: chunk:federal_register_of_legislation:F2024L01730:schedule:1:p3
Version: federal_register_of_legislation:F2024L01730
Segment Type: schedule
Provision Reference: sch 1 (pt 3/30)
Character Range: 11766–14529

C14251  P14251  56  5     28

[10] Schedule 1, Part 1, entries for Bortezomib in the form Powder for injection 1 mg
omit:
Bortezomib  Powder for injection 1 mg  Injection  DBL Bortezomib  PF  MP  C11099 C13745     See Note 3  See Note 3     1     D(100)

[11] Schedule 1, Part 1, entries for Bortezomib in the form Powder for injection 2.5 mg
omit:
Bortezomib  Powder for injection 2.5 mg  Injection  DBL Bortezomib  PF  MP  C11099 C13745     See Note 3  See Note 3     1     D(100)

[12] Schedule 1, Part 1, entries for Celecoxib in the form Capsule 100 mg
omit:
Celecoxib  Capsule 100 mg  Oral  NOUMED CELECOXIB  VO  MP NP  C4907 C4962     60  3     60

[13] Schedule 1, Part 1, entries for Celecoxib in the form Capsule 200 mg
omit:
Celecoxib  Capsule 200 mg  Oral  NOUMED CELECOXIB  VO  MP NP  C4907 C4962     30  3     30

[14] Schedule 1, Part 1, entry for Dasatinib in the form Tablet 20 mg [Brand: Dasatinib ARX; Maximum Quantity: 60; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9367 C9468 C9469
(b) insert in numerical order in the column headed "Circumstances": C16228 C16229 C16252
(c) omit from the column headed "Purposes": P9367 P9468 P9469
(d) insert in numerical order in the column headed "Purposes": P16228 P16229 P16252
[15] Schedule 1, Part 1, entry for Dasatinib in the form Tablet 20 mg [Brand: Dasatinib Dr.Reddy's; Maximum Quantity: 60; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9367 C9468 C9469
(b) insert in numerical order in the column headed "Circumstances": C16228 C16229 C16252
(c) omit from the column headed "Purposes": P9367 P9468 P9469
(d) insert in numerical order in the column headed "Purposes": P16228 P16229 P16252
[16] Schedule 1, Part 1, entry for Dasatinib in the form Tablet 20 mg [Brand: Dasatinib Sandoz; Maximum Quantity: 60; Number of
Repeats: 2]
(a) omit from the column headed "Circumstances": C9367 C9468 C9469
(b) insert in numerical order in the column headed "Circumstances": C16228 C16229 C16252
(c) omit from the column headed "Purposes": P9367 P9468 P9469
(d) insert in numerical order in the column headed "Purposes": P16228 P16229 P16252
[17] Schedule 1, Part 1, entry for Dasatinib in the form Tablet 20 mg [Brand: Dasatinib SUN; Maximum Quantity: 60; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C9367 C9468 C9469
(b) insert in numerical order in the column headed "Circumstances": C16228 C16229 C16252
(c) omit from the column headed "Purposes": P9367 P9468 P9469
(d) insert in numerical order in the column headed "Purposes": P16228 P16229 P16252
[18] Schedule 1, Part 1, entry for Dasatinib in the form Tablet 20 mg [Brand: DASATINIB-TEVA; Maximum Quantity: 60; Number of
Repeats: 2]
(a) omit from the column headed